Crossref
Dacarbazine remains the reference standard treatment for metastatic melanoma
Evidence-based Oncology · 2000
DOI: 10.1054/ebon.2000.0015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Evidence-based Oncology, 2000. Verfasst von Michael J. Walker. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Walker, M. J. (2000). Dacarbazine remains the reference standard treatment for metastatic melanoma. Evidence-based Oncology. https://doi.org/10.1054/ebon.2000.0015
Vancouver
Walker MJ. Dacarbazine remains the reference standard treatment for metastatic melanoma. Evidence-based Oncology. 2000. doi:10.1054/ebon.2000.0015
BibTeX
@article{Walker2000,
author = {Walker, Michael J.},
title = {Dacarbazine remains the reference standard treatment for metastatic melanoma},
journal = {Evidence-based Oncology},
year = {2000},
doi = {10.1054/ebon.2000.0015}
}
EUVIMED